Did Lois Frankel buy Haemonetics stock?

Common questions

Did Lois Frankel buy Haemonetics stock?

Yes. Lois Frankel disclosed 1 purchase and 5 sales of Haemonetics (HAE) stock between Jun 7, 2018 and May 7, 2021, in STOCK Act reports. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $5K-$75K.

How big were Lois Frankel's Haemonetics trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $5K-$75K.

Did Lois Frankel make these Haemonetics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Lois Frankel still own Haemonetics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Lois Frankel report these trades?

The latest filing is dated May 25, 2021. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.